FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:729-730 March 6, 1997 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Drazen, J. M.

To the Editor: The study by Drazen et al. (Sept. 19 issue)¹ demonstrates the safety of the regular use of inhaled -agonists in a controlled setting among patients with mild asthma. We fear, however, that this result may create a false sense of security among patients and their physicians that could be conducive to the inappropriate use of these very effective bronchodilators. We would like to remind readers that our long-term epidemiologic studies have shown that the excessive use of -agonists is associated with a very high risk of fatal or near-fatal asthma ² and that the threshold of safety is . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.